MIAMI--(BUSINESS WIRE)--April 24, 2006--DOR BioPharma, Inc. (OTCBB:DORB - News; "DOR" or the "Company"), announced today that the European Commission and the centralized European Agency for the Evaluation of Medicinal Products (EMEA) has granted DOR incentives for Small and Medium Sized Enterprises (SME).
